FACTORS ASSOCIATED WITH BLEEDING EVENTS IN PATIENTS ON RIVAROXABAN FOR NON-VALVULAR ATRIAL FIBRILLATION: A REAL WORLD EXPERIENCE

被引：1
|
作者：
Akhtar, Tauseef [1 ]
Mattumpuram, Jishanth [1 ]
Fugar, Setri [1 ]
Ranka, Sagar [1 ]
Fratti, Juan Del Cid [1 ]
Mann, Hashim [1 ]
Uprety, Alok [1 ]
Putta, Aakash [1 ]
Golzar, Yasmeen [1 ]
机构：
[1] John H Stroger Hosp Cook Cty, Chicago, IL USA
来源：
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY | 2019年 / 73卷 / 09期
关键词：
D O I：
10.1016/S0735-1097(19)31079-4
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1267-270
引用
收藏
页码：471 / 471
页数：1
相关论文
共 50 条
  • [41] Population pharmacokinetic and pharmacodynamic analysis of rivaroxaban in Chinese patients with non-valvular atrial fibrillation
    Xiao-qin Liu
    Yu-fei Zhang
    Hong-yan Ding
    Ming-ming Yan
    Zheng Jiao
    Ming-kang Zhong
    Chun-lai Ma
    [J]. Acta Pharmacologica Sinica, 2022, 43 : 2723 - 2734
  • [42] Population pharmacokinetic and pharmacodynamic analysis of rivaroxaban in Chinese patients with non-valvular atrial fibrillation
    Liu, Xiao-qin
    Zhang, Yu-fei
    Ding, Hong-yan
    Yan, Ming-ming
    Jiao, Zheng
    Zhong, Ming-kang
    Ma, Chun-lai
    [J]. ACTA PHARMACOLOGICA SINICA, 2022, 43 (10) : 2723 - 2734
  • [43] The EXPAND study: Efficacy and safety of rivaroxaban in Japanese patients with non-valvular atrial fibrillation
    Shimokawa, Hiroaki
    Yamashita, Takeshi
    Uchiyama, Shinichiro
    Kitazono, Takanari
    Shimizu, Wataru
    Ikeda, Takanori
    Kamouchi, Masahiro
    Kaikita, Koichi
    Fukuda, Koji
    Origasa, Hideki
    Sakuma, Ichiro
    Saku, Keijiro
    Okumura, Yasuo
    Nakamura, Yuichiro
    Morimoto, Hideo
    Matsumoto, Naoki
    Tsuchida, Akihito
    Ako, Junya
    Sugishita, Nobuyoshi
    Shimizu, Shogo
    Atarashi, Hirotsugu
    Inoue, Hiroshi
    [J]. INTERNATIONAL JOURNAL OF CARDIOLOGY, 2018, 258 : 126 - 132
  • [44] Major bleeding in a post-marketing assessment of 39,052 non-valvular atrial fibrillation patients on rivaroxaban
    Peacock, W. F.
    Patel, M.
    Tamayo, S.
    Sicignano, N.
    Hopf, K.
    Yuan, Z.
    [J]. EUROPEAN HEART JOURNAL, 2015, 36 : 687 - 687
  • [45] Real-world bleeding risk among non-valvular atrial fibrillation (NVAF) patients prescribed apixaban, dabigatran, rivaroxaban and warfarin: analysis of electronic health records
    Lin, I.
    Masseria, C.
    Mardekian, J.
    Frean, M.
    Phatak, H.
    Kamble, S.
    Abdulsattar, Y.
    Petkun, W.
    Menzin, J.
    Lip, G. Y. H.
    [J]. EUROPEAN HEART JOURNAL, 2015, 36 : 1084 - 1084
  • [46] Rivaroxaban in Non-Valvular Atrial Fibrillation: a Prospective Studies and Clinical Practice
    Fonyakin, A. V.
    [J]. KARDIOLOGIYA, 2016, 56 (08) : 87 - 92
  • [47] Creatinine clearance and inappropriate dose of rivaroxaban in Japanese patients with non-valvular atrial fibrillation
    Yagi, Naoharu
    Suzuki, Shinya
    Arita, Takuto
    Otsuka, Takayuki
    Semba, Hiroaki
    Kano, Hiroto
    Matsuno, Shunsuke
    Kato, Yuko
    Uejima, Tokuhisa
    Oikawa, Yuji
    Yajima, Junji
    Matsuhama, Minoru
    Yamashita, Takeshi
    [J]. HEART AND VESSELS, 2020, 35 (01) : 110 - 117
  • [48] Medication adherence to direct anticoagulants in patients with non-valvular atrial fibrillation - a real world analysis
    Brizido, Catarina
    Ferreira, Antonio Miguel
    Lopes, Pedro
    Strong, Christopher
    Mendes, Gustavo Sa
    Gama, Francisco Fernandes
    Durazzo, Anai
    Rodrigues, Gustavo Rocha
    Matos, Daniel
    Guerreiro, Sara
    Madeira, Sergio
    Ferreira, Jorge
    Adragao, Pedro
    Mendes, Miguel
    [J]. REVISTA PORTUGUESA DE CARDIOLOGIA, 2021, 40 (09) : 669 - 675
  • [49] CHOICE OF ANTITHROMBOTIC DRUG IN NON-VALVULAR ATRIAL FIBRILLATION PATIENTS IN REAL-WORLD PRACTICE
    Citarella, A.
    Cammarota, S.
    Creazzola, S.
    De Marino, C.
    Izzo, P.
    La Bella, G.
    Piscitelli, R.
    Romagnuolo, F.
    Esposito, E.
    Guida, A.
    [J]. VALUE IN HEALTH, 2015, 18 (07) : A380 - A380
  • [50] Suboptimal Management of Patients with Non-valvular Atrial Fibrillation: Real-world Clinical Setting
    Lau, Wallis C. Y.
    Chan, Esther W.
    Wong, Ian C. K.
    [J]. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2015, 24 : 380 - 380
12345